nipocalimab-aahu

nipocalimab-aahu (IMAAVY) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

IMAAVY is a marketed brand name for nipocalimab-aahu. Check FDA Drugs@FDA for the current US label holder and prescribing information.

nipocalimab-aahu has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.